Works by Pignata, Sandro

Results: 122
    1

    Programmed death‐ligand 1 expression and prognostic significance in bevacizumab treated ovarian cancer patients: Results from the phase IV MITO16A/MaNGO OV‐2 translational study.

    Published in:
    Clinical & Translational Medicine, 2025, v. 15, n. 6, p. 1, doi. 10.1002/ctm2.70373
    By:
    • Basso‐Valentina, Francesca;
    • Canzonieri, Vincenzo;
    • De Cecio, Rossella;
    • Arenare, Laura;
    • Lorusso, Domenica;
    • Cecere, Sabrina Chiara;
    • Pivetta, Eliana;
    • Russo, Daniela;
    • Di Mauro, Annabella;
    • Artioli, Grazia;
    • Spina, Anna;
    • De Angelis, Carmine;
    • Califano, Daniela;
    • Cinieri, Saverio;
    • Scognamiglio, Giosuè;
    • Salutari, Vanda;
    • Chiodini, Paolo;
    • Perrone, Francesco;
    • Pignata, Sandro;
    • Baldassarre, Gustavo
    Publication type:
    Article
    2
    3
    4
    5

    Ovarian Cancer Radiosensitivity: What Have We Understood So Far?

    Published in:
    Life (2075-1729), 2023, v. 13, n. 1, p. 6, doi. 10.3390/life13010006
    By:
    • Barcellini, Amelia;
    • Charalampopoulou, Alexandra;
    • De Cecco, Loris;
    • Fodor, Andrei;
    • Rabaiotti, Emanuela;
    • Candotti, Giorgio;
    • Secondino, Simona;
    • Facoetti, Angelica;
    • Locati, Laura Deborah;
    • Pignata, Sandro;
    • Orlandi, Ester;
    • Mangili, Giorgia
    Publication type:
    Article
    6

    Hypergastrinemia in rats with azoxymethane-induced colon cancers.

    Published in:
    International Journal of Cancer, 1995, v. 61, n. 2, p. 223, doi. 10.1002/ijc.2910610214
    By:
    • D'Agostino, Luciano;
    • Pignata, Sandro;
    • Tritto, Giovanni;
    • D'Adamo, Giuseppe;
    • Contegiacomo, Alma;
    • Daniele, Bruno;
    • Calderopoli, Rita;
    • Pizzi, Claudia;
    • Squame, Giovanni;
    • Mazzacca, Gabriele
    Publication type:
    Article
    7

    Costs of clinical trials with anticancer biological agents in an Oncologic Italian Cancer Center using the activity-based costing methodology.

    Published in:
    PLoS ONE, 2019, v. 14, n. 01, p. 1, doi. 10.1371/journal.pone.0210330
    By:
    • Pascarella, Giacomo;
    • Capasso, Arturo;
    • Nardone, Antonio;
    • Triassi, Maria;
    • Pignata, Sandro;
    • Arenare, Laura;
    • Ascierto, Paolo;
    • Curvietto, Marcello;
    • Maiolino, Piera;
    • D’Aniello, Roberta;
    • Montanino, Agnese;
    • Laudato, Francesca;
    • De Feo, Gianfranco;
    • Botti, Gerardo;
    • Perrone, Francesco;
    • Petrillo, Antonella;
    • Cavalcanti, Ernesta;
    • Lastoria, Secondo;
    • Maurea, Nicola;
    • Morabito, Alessandro
    Publication type:
    Article
    8

    Efficacy and safety data in elderly patients with metastatic renal cell carcinoma included in the nivolumab Expanded Access Program (EAP) in Italy.

    Published in:
    PLoS ONE, 2018, p. 1, doi. 10.1371/journal.pone.0199642
    By:
    • Vitale, Maria Giuseppa;
    • Scagliarini, Sarah;
    • Galli, Luca;
    • Pignata, Sandro;
    • Lo Re, Giovanni;
    • Berruti, Alfredo;
    • Defferrari, Carlotta;
    • Spada, Massimiliano;
    • Masini, Cristina;
    • Santini, Daniele;
    • Ciuffreda, Libero;
    • Ruggeri, Enzo Maria;
    • Bengala, Carmelo;
    • Livi, Lorenzo;
    • Fagnani, Daniele;
    • Bonetti, Andrea;
    • Giustini, Lucio;
    • Hamzaj, Alketa;
    • Procopio, Giuseppe;
    • Caserta, Claudia
    Publication type:
    Article
    9

    Inflammatory Indexes as Prognostic and Predictive Factors in Ovarian Cancer Treated with Chemotherapy Alone or Together with Bevacizumab. A Multicenter, Retrospective Analysis by the MITO Group (MITO 24).

    Published in:
    2018
    By:
    • Farolfi, Alberto;
    • Petrone, Micaela;
    • Scarpi, Emanuela;
    • Gallà, Valentina;
    • Greco, Filippo;
    • Casanova, Claudia;
    • Longo, Lucia;
    • Cormio, Gennaro;
    • Orditura, Michele;
    • Bologna, Alessandra;
    • Zavallone, Laura;
    • Ventriglia, Jole;
    • Franzese, Elisena;
    • Loizzi, Vera;
    • Giardina, Donatella;
    • Pigozzi, Eva;
    • Cioffi, Raffaella;
    • Pignata, Sandro;
    • Giorda, Giorgio;
    • De Giorgi, Ugo
    Publication type:
    journal article
    10

    Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study.

    Published in:
    BMC Cancer, 2008, v. 8, p. 1, doi. 10.1186/1471-2407-8-252
    By:
    • Pignata, Sandro;
    • Ferrandina, Gabriella;
    • Scarfone, Giovanna;
    • Scollo, Paolo;
    • Odicino, Franco;
    • Cormio, Gennaro;
    • Katsaros, Dionyssios;
    • Villa, Antonella;
    • Mereu, Liliana;
    • Ghezzi, Fabio;
    • Manzione, Luigi;
    • Lauria, Rossella;
    • Breda, Enrico;
    • Alletti, Desiderio Gueli;
    • Ballardini, Michela;
    • Lombardi, Alessandra Vernaglia;
    • Sorio, Roberto;
    • Mangili, Giorgia;
    • Priolo, Domenico;
    • Magni, Giovanna
    Publication type:
    Article
    11

    Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer: preliminary results of the MITO-2 randomized trial.

    Published in:
    BMC Cancer, 2006, v. 6, p. 202, doi. 10.1186/1471-2407-6-202
    By:
    • Pignata, Sandro;
    • Scambia, Giovanni;
    • Savarese, Antonella;
    • Breda, Enrico;
    • Scollo, Paolo;
    • De Vivo, Rocco;
    • Rossi, Emanuela;
    • Gebbia, Vittorio;
    • Natale, Donato;
    • Del Gaizo, Filomena;
    • Naglieri, Emanuele;
    • Ferro, Antonella;
    • Musso, Pietro;
    • D'Arco, Alfonso Maria;
    • Sorio, Roberto;
    • Pisano, Carmela;
    • Di Maio, Massimo;
    • Signoriello, Giuseppe;
    • Annunziata, Annalisa;
    • Perrone, Francesco
    Publication type:
    Article
    12
    13

    Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study.

    Published in:
    BMC Cancer, 2006, v. 6, p. 5, doi. 10.1186/1471-2407-6-5
    By:
    • Pignata, Sandro;
    • De Placido, Sabino;
    • Biamonte, Rosalbino;
    • Scambia, Giovanni;
    • Di Vagno, Giovanni;
    • Colucci, Giuseppe;
    • Febbraro, Antonio;
    • Marinaccio, Marco;
    • Lombardi, Alessandra Vernaglia;
    • Manzione, Luigi;
    • Cartení, Giacomo;
    • Nardi, Mario;
    • Danese, Saverio;
    • Valerio, Maria Rosaria;
    • de Matteis, Andrea;
    • Massidda, Bruno;
    • Gasparini, Giampietro;
    • Di Maio, Massimo;
    • Pisano, Carmela;
    • Perrone, Francesco
    Publication type:
    Article
    14

    Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells.

    Published in:
    Cancer Immunology, Immunotherapy, 2005, v. 54, n. 8, p. 781, doi. 10.1007/s00262-004-0636-3
    By:
    • Ottaiano, Alessandro;
    • di Palma, Antonella;
    • Napolitano, Maria;
    • Pisano, Carmen;
    • Pignata, Sandro;
    • Tatangelo, Fabiana;
    • Botti, Gerardo;
    • Acquaviva, Angela;
    • Castello, Giuseppe;
    • Ascierto, Paolo;
    • Iaffaioli, Rosario;
    • Scala, Stefania
    Publication type:
    Article
    15
    16

    Ovarian Cancer Translational Activity of the Multicenter Italian Trial in Ovarian Cancer (MITO) Group: Lessons Learned in 10 Years of Experience.

    Published in:
    Cells (2073-4409), 2020, v. 9, n. 4, p. 903, doi. 10.3390/cells9040903
    By:
    • Califano, Daniela;
    • Russo, Daniela;
    • Scognamiglio, Giosuè;
    • Losito, Nunzia Simona;
    • Spina, Anna;
    • Bello, Anna Maria;
    • Capiluongo, Anna;
    • Galdiero, Francesca;
    • De Cecio, Rossella;
    • Bevilacqua, Simona;
    • Gargiulo, Piera;
    • Marchesi, Edoardo;
    • Canevari, Silvana;
    • Perrone, Francesco;
    • Daniele, Gennaro;
    • De Cecco, Loris;
    • Mezzanzanica, Delia;
    • Pignata, Sandro
    Publication type:
    Article
    17

    Pazopanib in Metastatic Renal Cancer: A "Real-World" Experience at National Cancer Institute "Fondazione G. Pascale".

    Published in:
    Frontiers in Pharmacology, 2016, v. 7, p. 1, doi. 10.3389/fphar.2016.00287
    By:
    • Cecere, Sabrina C.;
    • Rossetti, Sabrina;
    • Cavaliere, Carla;
    • Pepa, Chiara Della;
    • Di Napoli, Marilena;
    • Crispo, Anna;
    • Iovane, Gelsomina;
    • Piscitelli, Raffaele;
    • Sorrentino, Domenico;
    • Ciliberto, Gennaro;
    • Maiolino, Piera;
    • Muto, Paolo;
    • Perdonà, Sisto;
    • Berretta, Massimiliano;
    • Pignata, Sandro;
    • Facchini, Gaetano;
    • D'Aniello, Carmine
    Publication type:
    Article
    18

    Very Early PSA Response to Abiraterone in mCRPC Patients: A Novel Prognostic Factor Predicting Overall Survival.

    Published in:
    Frontiers in Pharmacology, 2016, p. 1, doi. 10.3389/fphar.2016.00123
    By:
    • Facchini, Gaetano;
    • Caffo, Orazio;
    • Ortega, Cinzia;
    • D'Aniello, Carmine;
    • Di Napoli, Marilena;
    • Cecere, Sabrina C.;
    • Pepa, Chiara Della;
    • Crispo, Anna;
    • Maines, Francesca;
    • Ruatta, Fiorella;
    • Iovane, Gelsomina;
    • Pisconti, Salvatore;
    • Montella, Maurizio;
    • Berretta, Massimiliano;
    • Pignata, Sandro;
    • Cavaliere, Carla;
    • Di Maio, Massimo;
    • Russo, Giorgio I.
    Publication type:
    Article
    19

    From Clinical Trials to the Front Line: Vinflunine for Treatment of Urothelial Cell Carcinoma at the National Cancer Institute of Naples.

    Published in:
    Frontiers in Pharmacology, 2016, p. 1, doi. 10.3389/fphar.2016.00110
    By:
    • Facchini, Gaetano;
    • Pepa, Chiara Della;
    • Cavaliere, Carla;
    • Cecere, Sabrina C.;
    • Di Napoli, Marilena;
    • Iovane, Gelsomina;
    • Pignata, Sandro;
    • D'Aniello, Carmine;
    • Pisconti, Salvatore;
    • Crispo, Anna;
    • Montella, Maurizio;
    • Maiolino, Piera;
    • Tramontano, Teresa;
    • Piscitelli, Raffaele;
    • Berretta, Massimiliano;
    • Sorrentino, Domenico;
    • Perdonà, Sisto;
    • Cimino, Sebastiano;
    • Caraglia, Michele
    Publication type:
    Article
    20
    21

    Gemcitabine versus bacille Calmette-Guérin after initial bacille Calmette-Guérin failure in non-muscle-invasive bladder cancer: a multicenter prospective randomized trial.

    Published in:
    2010
    By:
    • Di Lorenzo G;
    • Perdonà S;
    • Damiano R;
    • Faiella A;
    • Cantiello F;
    • Pignata S;
    • Ascierto P;
    • Simeone E;
    • De Sio M;
    • Autorino R;
    • Di Lorenzo, Giuseppe;
    • Perdonà, Sisto;
    • Damiano, Rocco;
    • Faiella, Adriana;
    • Cantiello, Francesco;
    • Pignata, Sandro;
    • Ascierto, Paolo;
    • Simeone, Ester;
    • De Sio, Marco;
    • Autorino, Riccardo
    Publication type:
    journal article
    22
    23

    Concomitant medication of cetirizine in advanced melanoma could enhance anti-PD-1 efficacy by promoting M1 macrophages polarization.

    Published in:
    2022
    By:
    • Mallardo, Domenico;
    • Simeone, Ester;
    • Vanella, Vito;
    • Vitale, Maria Grazia;
    • Palla, Marco;
    • Scarpato, Luigi;
    • Paone, Miriam;
    • De Cristofaro, Teresa;
    • Borzillo, Valentina;
    • Cortellini, Alessio;
    • Sparano, Francesca;
    • Pignata, Sandro;
    • Fiore, Francesco;
    • Caracò, Corrado;
    • Maiolino, Piera;
    • Petrillo, Antonella;
    • Cavalcanti, Ernesta;
    • Lastoria, Secondo;
    • Muto, Paolo;
    • Budillon, Alfredo
    Publication type:
    journal article
    24

    Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st–2nd, 2021.

    Published in:
    Journal of Translational Medicine, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12967-022-03471-y
    By:
    • Ascierto, Paolo A.;
    • Avallone, Antonio;
    • Bhardwaj, Nina;
    • Bifulco, Carlo;
    • Bracarda, Sergio;
    • Brody, Joshua D.;
    • Buonaguro, Luigi;
    • Demaria, Sandra;
    • Emens, Leisha A.;
    • Ferris, Robert L.;
    • Galon, Jérôme;
    • Khleif, Samir N.;
    • Klebanoff, Christopher A.;
    • Laskowski, Tamara;
    • Melero, Ignacio;
    • Paulos, Chrystal M.;
    • Pignata, Sandro;
    • Ruella, Marco;
    • Svane, Inge Marie;
    • Taube, Janis M.
    Publication type:
    Article
    25
    26
    27
    28
    29

    Second-Line Chemotherapy in Recurrent Clear Cell Ovarian Cancer: Results from the Multicenter Italian Trials in Ovarian Cancer (MITO-9)

    Published in:
    2014
    By:
    • Esposito, Francesca;
    • Cecere, Sabrina Chiara;
    • Magazzino, Francescapaola;
    • Katsaros, Dionyssios;
    • Ottaiano, Alessandro;
    • Gadducci, Angiolo;
    • Pisano, Carmela;
    • Scalone, Simona;
    • Rabaiotti, Emanuela;
    • Salutari, Vanda;
    • Cormio, Gennaro;
    • Canuto, Emilie Marion;
    • Greggi, Stefano;
    • Savarese, Antonella;
    • Marinaccio, Marco;
    • Scollo, Paolo;
    • Santeufemia, Davide Adriano;
    • Sacco, Cosimo;
    • Facchini, Gaetano;
    • Pignata, Sandro
    Publication type:
    Journal Article
    30

    Second-Line Chemotherapy in Recurrent Clear Cell Ovarian Cancer: Results from the Multicenter Italian Trials in Ovarian Cancer (MITO-9).

    Published in:
    Oncology, 2014, v. 86, n. 5/6, p. 351, doi. 10.1159/000358730
    By:
    • Esposito, Francesca;
    • Cecere, Sabrina Chiara;
    • Magazzino, Francescapaola;
    • Katsaros, Dionyssios;
    • Ottaiano, Alessandro;
    • Gadducci, Angiolo;
    • Pisano, Carmela;
    • Scalone, Simona;
    • Rabaiotti, Emanuela;
    • Salutari, Vanda;
    • Cormio, Gennaro;
    • Canuto, Emilie Marion;
    • Greggi, Stefano;
    • Savarese, Antonella;
    • Marinaccio, Marco;
    • Scollo, Paolo;
    • Santeufemia, Davide Adriano;
    • Sacco, Cosimo;
    • Facchini, Gaetano;
    • Pignata, Sandro
    Publication type:
    Article
    31
    32

    Extending the Platinum-Free Interval with a Non-Platinum Therapy in Platinum-Sensitive Recurrent Ovarian Cancer.

    Published in:
    Oncology, 2006, v. 71, n. 5/6, p. 320, doi. 10.1159/000108592
    By:
    • Pignata, Sandro;
    • Ferrandina, Gabriella;
    • Scarfone, Giovanna;
    • Scollo, Paolo;
    • Odicino, Franco;
    • Selvaggi, Luigi;
    • Katsaros, Dionyssios;
    • Frigerio, Luigi;
    • Mereu, Liliana;
    • Ghezzi, Fabio;
    • Manzione, Luigi;
    • Lauria, Rossella;
    • Breda, Enrico;
    • Marforio, Giovanna;
    • Ballardini, Michela;
    • Lombardi, Alessandra Vernaglia;
    • Sorio, Roberto;
    • Tumolo, Salvatore;
    • Costa, Bruno;
    • Magni, Giovanna
    Publication type:
    Article
    33

    A Phase I Study of Paclitaxel and Epirubicin, without and with Filgrastim, for the Treatment of Platinum-Resistant Advanced Ovarian Cancer.

    Published in:
    Oncology, 1999, v. 56, n. 4, p. 267, doi. 10.1159/000011977
    By:
    • Lauria, Rossella;
    • Ferrari, Ettore;
    • Tramontana, Sergio;
    • Morabito, Alessandro;
    • Perrone, Francesco;
    • Maffeo, Antonio;
    • Fiorentino, Roberto;
    • Casella, Gennaro;
    • Iodice, Francesco;
    • Ricchi, Paolo;
    • Carlomagno, Chiara;
    • Varriale, Elisa;
    • De Placido, Giuseppe;
    • De Placido, Sabino;
    • Bianco, Angelo Raffaele;
    • Pignata, Sandro
    Publication type:
    Article
    34

    Acute Toxicity in Hypofractionated/Stereotactic Prostate Radiotherapy of Elderly Patients: Use of the Image-guided Radio Therapy (IGRT) Clarity System.

    Published in:
    In Vivo, 2021, v. 35, n. 3, p. 1849, doi. 10.21873/invivo.12447
    By:
    • DI FRANCO, ROSSELLA;
    • BORZILLO, VALENTINA;
    • ALBERTI, DOMINGO;
    • AMETRANO, GIANLUCA;
    • PETITO, ANGELA;
    • COPPOLARO, ANDREA;
    • TARANTINO, ILARIA;
    • ROSSETTI, SABRINA;
    • PIGNATA, SANDRO;
    • IOVANE, GELSOMINA;
    • PERDONÀ, SISTO;
    • QUARTO, GIUSEPPE;
    • GRIMALDI, GIOVANNI;
    • IZZO, ALESSANDRO;
    • CASTALDO, LUIGI;
    • MUSCARIELLO, RAFFAELE;
    • SERRA, MARCELLO;
    • FACCHINI, GAETANO;
    • MUTO, PAOLO
    Publication type:
    Article
    35

    Early Decline in Cancer Antigen 125 as a Surrogate for Progression-Free Survival in Recurrent Ovarian Cancer.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 17, p. 1338, doi. 10.1093/jnci/djr282
    By:
    • Lee, Chee K.;
    • Friedlander, Michael;
    • Brown, Chris;
    • Gebski, Val J.;
    • Georgoulopoulos, Alexander;
    • Vergote, Ignace;
    • Pignata, Sandro;
    • Donadello, Nicoletta;
    • Schmalfeldt, Barbara;
    • Delva, Rémy;
    • Mirza, Mansoor Raza;
    • Sauthier, Philippe;
    • Pujade-Lauraine, Eric;
    • Lord, Sarah J.;
    • Simes, R. John
    Publication type:
    Article
    36

    Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real‐world results from an expanded access programme.

    Published in:
    BJU International, 2019, v. 123, n. 1, p. 98, doi. 10.1111/bju.14461
    By:
    • De Giorgi, Ugo;
    • Cartenì, Giacomo;
    • Giannarelli, Diana;
    • Basso, Umberto;
    • Galli, Luca;
    • Cortesi, Enrico;
    • Caserta, Claudia;
    • Pignata, Sandro;
    • Sabbatini, Roberto;
    • Bearz, Alessandra;
    • Buti, Sebastiano;
    • Lo Re, Giovanni;
    • Berruti, Alfredo;
    • Bracarda, Sergio;
    • Cognetti, Francesco;
    • Rastelli, Francesca;
    • Fornarini, Giuseppe;
    • Porta, Camillo;
    • Turci, Daniele;
    • Sternberg, Cora N.
    Publication type:
    Article
    37

    Regulatory T cells, interleukin ( IL)-6, IL-8, Vascular endothelial growth factor ( VEGF), CXCL10, CXCL11, epidermal growth factor ( EGF) and hepatocyte growth factor ( HGF) as surrogate markers of host immunity in patients with renal cell carcinoma.

    Published in:
    BJU International, 2013, v. 112, n. 5, p. 686, doi. 10.1111/bju.12068
    By:
    • Polimeno, Marianeve;
    • Napolitano, Maria;
    • Costantini, Susan;
    • Portella, Luigi;
    • Esposito, Arianna;
    • Capone, Francesca;
    • Guerriero, Eliana;
    • Trotta, AnnaMaria;
    • Zanotta, Serena;
    • Pucci, Luigi;
    • Longo, Nicola;
    • Perdonà, Sisto;
    • Pignata, Sandro;
    • Castello, Giuseppe;
    • Scala, Stefania
    Publication type:
    Article
    38

    Efficacy of PARP inhibitors in advanced high-grade serous ovarian cancer according to BRCA domain mutations and mutation type.

    Published in:
    Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1412807
    By:
    • Buonaiuto, Roberto;
    • Neola, Giuseppe;
    • Caltavituro, Aldo;
    • Longobardi, Alessandra;
    • Mangiacotti, Federica Pia;
    • Cefaliello, Amedeo;
    • Lamia, Maria Rosaria;
    • Pepe, Francesco;
    • Ventriglia, Jole;
    • Malapelle, Umberto;
    • Troncone, Giancarlo;
    • Giuliano, Mario;
    • Arpino, Grazia;
    • Pignata, Sandro;
    • De Angelis, Carmine
    Publication type:
    Article
    39

    Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey.

    Published in:
    Journal of Gynecologic Oncology, 2024, v. 35, n. 3, p. 1, doi. 10.3802/jgo.2024.35.e70
    By:
    • Palaia, Innocenza;
    • Caruso, Giuseppe;
    • Di Donato, Violante;
    • Turetta, Camilla;
    • Savarese, Antonella;
    • Perniola, Giorgia;
    • Gallo, Roberta;
    • Giannini, Andrea;
    • Salutari, Vanda;
    • Bogani, Giorgio;
    • Tomao, Federica;
    • Giannarelli, Diana;
    • Gentile, Gabriella;
    • Musella, Angela;
    • Muzii, Ludovico;
    • Pignata, Sandro
    Publication type:
    Article
    40
    41

    Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups.

    Published in:
    Journal of Gynecologic Oncology, 2020, v. 31, n. 6, p. 1, doi. 10.3802/jgo.2020.31.e92
    By:
    • Bogani, Giorgio;
    • Apolone, Giovanni;
    • Ditto, Antonino;
    • Scambia, Giovanni;
    • Panici, Pierluigi Benedetti;
    • Angioli, Roberto;
    • Pignata, Sandro;
    • Greggi, Stefano;
    • Scollo, Paolo;
    • Delia, Mezzanzanica;
    • Franchi, Massimo;
    • Martinelli, Fabio;
    • Signorelli, Mauro;
    • Lopez, Salvatore;
    • Di Donato, Violante;
    • Valabrega, Giorgio;
    • Ferrandina, Gabriella;
    • Palaia, Innocenza;
    • Bergamini, Alice;
    • Bocciolone, Luca
    Publication type:
    Article
    42
    43
    44
    45

    A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trial.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 5, p. 1021, doi. 10.1007/s00280-009-0958-0
    By:
    • Pisano, Carmela;
    • Morabito, Alessandro;
    • Sorio, Roberto;
    • Breda, Enrico;
    • Lauria, Rossella;
    • Gebbia, Vittorio;
    • Scaltriti, Laura;
    • Scalone, Simona;
    • Zagonel, Vittorina;
    • Greggi, Stefano;
    • Beneduce, Gerardo;
    • Losito, Simona;
    • Gallo, Ciro;
    • Di Maio, Massimo;
    • Forestieri, Valeria;
    • Pignata, Sandro
    Publication type:
    Article
    46
    47

    Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitors.

    Published in:
    Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2023.1247291
    By:
    • Arezzo, Francesca;
    • Giannone, Gaia;
    • Castaldo, Daniele;
    • Scotto, Giulia;
    • Tuninetti, Valentina;
    • Turinetto, Margherita;
    • Bartoletti, Michele;
    • Mammoliti, Serafina;
    • Artioli, Grazia;
    • Mangili, Giorgia;
    • Salutari, Vanda;
    • Lorusso, Domenica;
    • Cormio, Gennaro;
    • Loizzi, Vera;
    • Zamagni, Claudio;
    • Savarese, Antonella;
    • Di Maio, Massimo;
    • Ronzino, Graziana;
    • Pisano, Carmela;
    • Pignata, Sandro
    Publication type:
    Article
    48

    Stereotactic body radiotherapy with CyberKnife® System for low- and intermediate-risk prostate cancer: clinical outcomes and toxicities of CyPro Trial.

    Published in:
    Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1270498
    By:
    • Borzillo, Valentina;
    • Scipilliti, Esmeralda;
    • Pezzulla, Donato;
    • Serra, Marcello;
    • Ametrano, Gianluca;
    • Quarto, Giuseppe;
    • Perdonà, Sisto;
    • Rossetti, Sabrina;
    • Pignata, Sandro;
    • Crispo, Anna;
    • Di Gennaro, Piergiacomo;
    • D'Alesio, Valentina;
    • Arrichiello, Cecilia;
    • Buonanno, Francesca;
    • Mercogliano, Simona;
    • Russo, Antonio;
    • Tufano, Antonio;
    • Di Franco, Rossella;
    • Muto, Paolo
    Publication type:
    Article
    49

    Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitors.

    Published in:
    Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1247291
    By:
    • Arezzo, Francesca;
    • Giannone, Gaia;
    • Castaldo, Daniele;
    • Scotto, Giulia;
    • Tuninetti, Valentina;
    • Turinetto, Margherita;
    • Bartoletti, Michele;
    • Mammoliti, Serafina;
    • Artioli, Grazia;
    • Mangili, Giorgia;
    • Salutari, Vanda;
    • Lorusso, Domenica;
    • Cormio, Gennaro;
    • Loizzi, Vera;
    • Zamagni, Claudio;
    • Savarese, Antonella;
    • Di Maio, Massimo;
    • Ronzino, Graziana;
    • Pisano, Carmela;
    • Pignata, Sandro
    Publication type:
    Article
    50